Advertisement

Topics

Pharmaxis Company Profile

17:53 EDT 23rd September 2018 | BioPortfolio

Pharmaxis Ltd is a specialist pharmaceutical company established to research, development and bring to market human therapeutic products to treat chronic respiratory and autoimmune diseases. Founded in 1998, Pharmaxis was listed on the Australian Stock Exchange in November, 2003 where it is traded under the symbol PXS, and listed on the NASDAQ in August, 2005 where it is traded under the symbol PXSL. The company takes a fully integrated approach to the development of pharmaceutical products for human use and is involved in : the basis research, preclinical development, manufacture and release of its products; the design, management and control of clinical trials; and sales and marketing. Our mission is to build an internationally successful pharmaceutical business by bringing innovative medicines to patients.

Location

Unit 2, 10 Rodborough Rd
Frenchs Forest
New South Wales
2086
Australia

Contact

Phone: +61 2 9454 7200
Fax: +61 2 9451 3622
Email: info@pharmaxis.com.au


News Articles [12 Associated News Articles listed on BioPortfolio]

What’s behind Pharmaxis’ recent deal with Boehringer Ingleheim?

Gary Philips, CEO to Pharmaxis, reveals the reasons behind the company’s change in direction, leading up to one of the largest deals for a phase I asset in Australia.

Deals this week: Pharmaxis, Almirall, Cipla Quality Chemical Industries

Pharmaxis has raised A$24m ($17.74m) in two tranches through a private placement of 73.8 million shares priced at A$0.325 ($0.24)...Read More... The post Deals this week: Pharmaxis, Almirall, Cipla Qu...

Arix Bioscience has 'keen eye' on Australia as it takes stake in ASX-listed Pharmaxis

Ed Rayner, investment director at Arix Bioscience Plc (LON:ARIX), discusses the decision to make their first investment in Australia by leading a sizeable funding round for ASX-listed Pharmaxis (ASX...

Boehringer Ingelheim acquires Pharmaxis’ anti-inflammatory candidate

Boehringer Ingelheim exercises option and acquires global ownership of Pharmaxis’ investigational anti-inflammatory drug candidate PXS4728A, including associated intellectual property rights. PXS472...

Arix Taps Australia's 'Undervalued' Pharmaxis As First VIPE, More Planned

UK-listed Arix completed its first Venture Investment in Public Equity (VIPE), leading a A$24m (£13.4m) investment in Australian biotech Pharmaxis.   

Arix Bioscience takes stake in Aussie fibrosis specialist Pharmaxis

Arix led a A$24mln (£13.4mln) primary placing and will invest A$14.2mln itself in two tranches

XFRA UUD: AUSSETZUNG/SUSPENSION

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL PHARMAXIS LT...

Nucala Among Flurry Of New Respiratory Products On Indian Horizon

Novel asthma/COPD drugs, including GlaxoSmithKline’s biologic therapy Nucala, are on the horizon in India, set to expand treatment options in...  &#

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Aridol bronchial challenge test kit [Pharmaxis Ltd]

These highlights do not include all the information needed to use ARIDOL safely and effectively. See full prescribing information for ARIDOL. ARIDOL™ (mannitol inhalation powder) Bronchial Challenge...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [4 Associated Companies listed on BioPortfolio]

Pharmaxis Ltd

Pharmaxis (ACN 082 811 630) is a specialist pharmaceutical company involved in the research, development and commercialization of therapeutic products for chronic respiratory diso...

Pharmaxis

Pharmaxis Ltd is a specialist pharmaceutical company established to research, development and bring to market human therapeutic products to treat chronic respiratory and autoimmune diseases. Founded ...

Pharmaxis Ltd.

Pharmaxis, Inc.

More Information about "Pharmaxis" on BioPortfolio

We have published hundreds of Pharmaxis news stories on BioPortfolio along with dozens of Pharmaxis Clinical Trials and PubMed Articles about Pharmaxis for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pharmaxis Companies in our database. You can also find out about relevant Pharmaxis Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record